Position in DRTS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$259,261
+$113,556 QoQ
Shares Held
20,609
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 14 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DRTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOODSTOCK CORP holds $23,238,186 across 10 Biotechnology names. DRTS ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,518 | $12,793,793 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
18,345 | $5,798,671 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,005 | $1,989,403 | |
| 4 | EYPT |
EyePoint, Inc.
|
68,465 | $979,049 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
242,756 | $517,070 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
8,176 | $467,830 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
9,191 | $306,887 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
This page
|
20,609 | $259,261 |
All Filings in DRTS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,261 | 20,609 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $145,705 | 20,609 | Shares | Sole | 2026-04-08 | |
| No filing history on record for this holder in this stock. | ||||||